Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30227097 | 0.94 | ALDH1A1 (0.41) | HCAR2AKR1B1TSHRTP53 | |
| SCHEMBL30227255 | 0.85 | ALDH1A1 (0.39) | HCAR2TSHR | |
| SCHEMBL254199 | 0.81 | CYP4F2 (0.43) | NAAACES2HCAR2EPHX1AKR1B1 | |
| SCHEMBL11240792 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL711761 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL7867044 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL7867046 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL2785037 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL20936457 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR | |
| SCHEMBL20915341 | 0.79 | NAAA (0.45) | NAAACES2HCAR2EPHX1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20230135772-A1 | CARBODIIMIDE COMPOSITION, CURING AGENT COMPOSITION, COATING COMPOSITION AND RESIN CURED PRODUCT | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4130154-A1 | CARBODIIMIDE COMPOSITION, HARDENER COMPOSITION, COATING COMPOSITION, AND CURED RESIN OBJECT | Asahi Kasei Kabushiki Kaisha (JP) | 2023-02-08 | — | — | EP | disclosed |
| US-6992209-B2 | Methods of forming alpha, beta-unsaturated acids and esters | BATTELLE MEMORIAL INSTITUTE (US) | 2006-01-31 | — | — | US | disclosed |
| US-20040110974-A1 | Methods of forming alpha, beta-unsaturated acids and esters | BATTELLE MEMORIAL INSTITUTE | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577373-B2 | Carbodiimide composition, curing agent composition, coating composition and resin cured product | CD38, PARP9, MCCC2 | NAAA 757/4885CES2 538/4885HCAR2 379/4885 |
| US-20040110974-A1 | Methods of forming alpha, beta-unsaturated acids and esters | ALOX5, ACSL1, ADH1A | NAAA 164/4885CES2 322/4885HCAR2 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.